naproxen has been researched along with n,n'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine in 1 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (n,n'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine) | Trials (n,n'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine) | Recent Studies (post-2010) (n,n'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 6 | 0 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambegaokar, SS; Begum, AN; Chen, PP; Cole, GM; Frautschy, SA; Glabe, CG; Kayed, R; Lim, GP; Simmons, MR; Ubeda, OJ; Yang, F | 1 |
1 other study(ies) available for naproxen and n,n'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine
Article | Year |
---|---|
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Benzothiazoles; Biphenyl Compounds; Blood-Brain Barrier; Brain; Cell Line, Tumor; Congo Red; Curcumin; Diamines; Humans; Ibuprofen; Mice; Mice, Transgenic; Naproxen; Peptide Fragments; Plaque, Amyloid; Protein Binding; Protein Denaturation; Protein Structure, Quaternary; Pyridazines; Solubility; Thiazoles | 2005 |